Alex Durso, MBA, currently serves as Executive Vice President of Quality at ILiAD Biotechnologies, LLC since July 2023. Prior to this role, Alex Durso held various positions including Executive Director and Vice President of Global Clinical Compliance at NOVAVAX INC starting in April 2021, as well as multiple senior management roles at Takeda from December 2013 to March 2021. Additional experience includes consulting at Compass Consulting Solutions, and leadership positions at Vertex Pharmaceuticals, Millennium Pharmaceuticals, PHT Corporation, Boehringer Ingelheim, and Genzyme Corporation. Alex Durso holds a Master of Business Administration from Curry College and a Bachelor of Fine Arts in Visual Design, Photography, and Typography from the University of Massachusetts Dartmouth.
Sign up to view 0 direct reports
Get started